InvestorsHub Logo
icon url

Florisun

08/30/16 3:32 PM

#157870 RE: luxe #157868

Great info Luxe

again :-) :-) :-)

liking what's ahead for CTIX

Thanks for that link, great stuff.
icon url

BonelessCat

08/30/16 3:36 PM

#157872 RE: luxe #157868

"Pfizer ($PFE) will have to keep waiting on its hopes for Xeljanz (tofacitinib) expansion. For now, the FDA has turned down the slow-starting med as a treatment for moderate to severe cases of plaque psoriasis."
http://www.fiercepharma.com/regulatory/fda-swats-down-pfizer-s-xeljanz-plaque-psoriasis
icon url

sox040713

08/30/16 3:36 PM

#157874 RE: luxe #157868

The FDA said no to Xeljanz for plaque psoriasis last year, so Prurisol would fill this void for Pfizer.

http://www.fiercepharma.com/regulatory/fda-swats-down-pfizer-s-xeljanz-plaque-psoriasis

It has demonstrated effectiveness in the treatment of psoriasis in Phase 3 studies.

icon url

Jhawker

08/30/16 3:41 PM

#157875 RE: luxe #157868

Luxe you get what you pay for. In order to get a partnership ctix needs an organization that can carry out their end of the agreement.